Armata Pharmaceuticals, Inc. Financial Ratios — ARMP Stock

Profitability (USD)

	2008 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2008	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-133.66	-216.39	-147.11	-149.46	-168.89	-132.62	-104.65	-120.1	- -	- -	- -
Return on Assets (%)	-116.33	-7.6	-204.11	66.19	-1.72	-75.89	-87.66	-105.19	-104.34	-68.28	-42.38	-44.59	-71.11	-20.47	-212.83
Return on Capital (%)	- -	- -	- -	-240.87	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	127.64	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-135.02	-596.99	-15,149.38	-2,955.5	-2,083.58	-5,177.69	-8,680	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-140.94	-606.02	-15,288.89	-2,994.13	-2,153.05	-5,319.62	-9,005.22	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	206.96	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-641.57	-79,732.1	5,650.12	-124	-7,459.23	-12,295.65	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-237.67	-167.17	-79,732.1	5,650.12	-108.63	-7,245.38	-11,163.48	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-237.67	-167.17	-90,181.48	4,166.75	-2,272.42	-9,336.92	-11,163.48	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	11.59	-35.6	95.22	22.07	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-6.39	-168.63	-147.11	-149.46	-168.89	-132.62	-104.65	-120.1	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2008 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2008	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	4	- -	- -	- -	1	- -	- -	3	13	38	49	120	127	288
ST Debt	- -	4	- -	- -	- -	1	- -	- -	1	2	2	17	9	43	5
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	11	36	32	111	83	283
Total Debt/EBITDA	- -	-0.92	- -	- -	- -	-0.06	- -	- -	-0.16	-0.64	-1.68	-1.35	-3.02	-3.08	-9.7
Net Debt/EBITDA	0.44	-0.7	1.66	0.54	0.95	0.36	0.51	0.8	0.34	0.44	0.45	0.41	-1.72	-2.07	-8.36
Total Debt/EBIT	- -	-0.91	- -	- -	- -	-0.06	- -	- -	-0.15	-0.61	-1.59	-1.32	-2.94	-2.98	-9.22
Net Debt/EBIT	0.42	-0.69	1.64	0.54	0.92	0.35	0.5	0.77	0.32	0.41	0.43	0.4	-1.68	-2.01	-7.95
EBITDA to Interest Expense	- -	-11.69	-4.28	- -	- -	- -	- -	- -	-19.05	-32.6	-353.95	- -	-15.2	-3.83	-1.79
EBITDA-CapEx/Interest Expense	- -	-11.85	-4.31	- -	- -	- -	- -	- -	-19.29	-33.91	-374.33	- -	-18.3	-4	-1.82
EBIT to Interest Expense	- -	-11.87	-4.32	- -	- -	- -	- -	- -	-20.5	-34.37	-372.22	- -	-15.57	-3.95	-1.88
Interest Expense	- -	- -	3	- -	- -	- -	- -	- -	1	1	- -	- -	3	11	17
Common Equity/Total Assets	-52.76	58.64	-55.11	12.01	40.37	53.56	69.41	71.29	57.34	47.72	36.4	37.65	-32.6	-55.55	-284.33
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	10.66	57.68	143.64	88.15	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	8.91	33.98	57.55	37.46	125.57	105.9	408.31
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	6.11	27.53	52.29	33.19	112.74	96.17	368.69
Total Debt/Equity (%)	- -	28.19	- -	- -	- -	8.26	- -	- -	19.62	69.74	149.58	135.3	-375.4	-263.47	-131.76
Total Debt/Capital (%)	- -	21.99	- -	- -	- -	7.63	- -	- -	16.4	41.08	59.93	57.5	136.31	161.17	414.88
Total Debt/Total Assets (%)	- -	16.53	- -	- -	- -	4.42	- -	- -	11.25	33.28	54.45	50.94	122.37	146.37	374.62
Net Debt to Equity	138.28	21.53	89.97	-191.48	-73.7	-50.48	-66.38	-96.26	-41.34	-47.34	-40.51	-41.16	-214.51	-177.22	-113.56
Net Debt/Capital (%)	58.03	17.71	47.36	209.32	-280.2	-101.93	-197.46	-2,573.19	-52.81	-39.93	-19.38	-21.2	91.98	122.97	408.72
EBITDA	-12	-4	-12	-12	-10	-13	-10	-10	-18	-20	-23	-36	-40	-41	-30
EBITDA-CapEx	-13	-4	-12	-13	-10	-14	-10	-10	-18	-21	-24	-38	-48	-43	-30
Operating Income (Loss)	-12	-4	-12	-12	-10	-14	-10	-11	-19	-22	-24	-37	-41	-42	-31

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2008 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2008	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.31	0.14	8.51	3.52	3.93	1.61	2.61	3.17	1.24	1.44	2.14	0.6	0.82	0.19	0.97
Current Ratio	1.42	0.27	8.64	3.76	4.2	1.78	2.74	3.27	1.36	1.62	3.11	1.09	1.16	0.23	1.19
Quick Ratio	1.39	0.25	8.52	3.58	3.98	1.62	2.61	3.17	1.24	1.52	2.76	0.94	1.03	0.21	1.02
CFO/Avg Current Liab	-2.38	-0.85	-1.49	-5.9	-4.6	-3.58	-3.34	-4.13	-4.18	-3.15	-4.09	-2.19	-2.29	-1.16	-0.9
Common Equity/Total Assets	-52.76	58.64	-55.11	12.01	40.37	53.56	69.41	71.29	57.34	47.72	36.4	37.65	-32.6	-55.55	-284.33
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	10.66	57.68	143.64	88.15	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	8.91	33.98	57.55	37.46	125.57	105.9	408.31
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	6.11	27.53	52.29	33.19	112.74	96.17	368.69
Total Debt/Equity (%)	- -	28.19	- -	- -	- -	8.26	- -	- -	19.62	69.74	149.58	135.3	-375.4	-263.47	-131.76
Total Debt/Capital (%)	- -	21.99	- -	- -	- -	7.63	- -	- -	16.4	41.08	59.93	57.5	136.31	161.17	414.88
Total Debt/Total Assets (%)	- -	16.53	- -	- -	- -	4.42	- -	- -	11.25	33.28	54.45	50.94	122.37	146.37	374.62
CFO/Total Liabilities	-94.35	-46.9	-9.86	-49.93	-52.08	-125.81	-269.8	-274.89	-143.51	-88.44	-53.13	-54.36	-36.36	-27.93	-8.72
CFO/CapEx	-13.96	-80.77	-61.69	-10.46	-46.58	-38.01	-158.48	-213.23	-69.56	-22.17	-18.08	-14.69	-5.82	-19.98	-47.53
Altman's Z-Score	-63.57	-261.13	-25.96	-64.64	-46.95	-77.47	-92.14	-65.8	-22.26	-10.71	-4.25	-5.09	-6.13	-8.55	-12.26

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2008 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2008	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	5.95	3.91	5.23	7.57	4.22	3.47	9.2	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	61.29	93.45	69.85	48.19	86.45	105.29	39.67	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2008 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2008	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	62	- -	91	41	23	7	10	7	32	56	149	45	117	67	229
- Cash & Cash Equivalents	5	1	20	7	9	6	5	8	6	10	10	15	14	9	9
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	4	- -	- -	- -	1	- -	- -	3	13	38	49	120	127	288
Enterprise Value	57	3	71	34	14	2	4	-1	29	59	176	79	224	184	508
Total Capital	-4	17	-23	3	13	11	8	8	17	32	63	85	88	78	69
Total Debt/Capital (%)	- -	21.99	- -	- -	- -	7.63	- -	- -	16.4	41.08	59.93	57.5	136.31	161.17	414.88
Total Debt / EV	- -	1.31	- -	- -	- -	0.34	- -	- -	0.1	0.22	0.22	0.62	0.54	0.69	0.57
EV/Sales	6.55	4.2	876.54	83.73	29.57	9.03	38.8	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	4	8	51	60	22	4	7	4	26	49	132	43	117	109	228
Diluted Enterprise Value	-1	11	30	54	12	-1	2	-4	23	52	160	76	224	226	507
EV per Share	1,411.14	- -	2,722.81	1,203.69	334.24	19.93	6.58	- -	2.93	3.17	6.5	2.18	6.2	5.09	13.95
TTM Sales	9	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-12	-4	-12	-12	-10	-13	-10	-10	-18	-20	-23	-36	-40	-41	-30
TTM Operating Income	-12	-4	-12	-12	-10	-14	-10	-11	-19	-22	-24	-37	-41	-42	-31
TTM Cash Flow to Firm	- -	-4	-3	-13	-10	-11	-9	-9	-15	-18	-24	-32	-45	-27	-9
TTM Free Cash Flow to Firm	- -	-4	-3	-11	-10	-10	-9	-9	-14	-17	-22	-30	-37	-25	-9

Multiples (USD)

Valuation Multiples API ChatGPT

	2008 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2008	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-0.46	-1.99	-8.17	-5.31	-2.25	-0.42	-0.73	-0.42	-1.7	-2.81	-5.93	-1.4	-2.98	-3.06	-9.02
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	57	3	71	34	14	2	4	-1	29	59	176	79	224	184	508
Low Price	910	560	700	490	385	50.4	9.38	2.15	2.45	2.52	2.82	0.83	1.07	1.8	0.9
EV/Sales	6.55	4.2	876.54	83.73	29.57	9.03	38.8	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	2.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-0.69	-7.54	-0.45	4.31	-4.27	-0.87	-1.06	-1.49	-1.34	-2.52	-4.45	-3.74	-1.15	-5.37	-0.61
Price/Earnings High	-1.73	-10.82	-0.98	8.13	-8.4	-2.22	-3.38	-3.21	-2.14	-5.12	-10.91	-6	-2.75	-8.56	-3.41
Price/Earnings Low	-0.13	-3.46	-0.14	0.77	-1.38	-0.15	-0.33	-0.24	-0.84	-1.86	-2.94	-0.77	-0.56	-3.44	-0.19
Price/Book Value	-16.53	- -	-4.02	11.88	1.84	0.75	1.24	0.79	2.21	2.96	5.85	1.24	-3.65	-1.39	-1.05
Price/Book Value Average	-54.22	- -	-2.59	22.72	3.94	3.65	2.61	3.63	2.65	3.37	4.56	4.03	-2.49	-2.12	-0.49
Price/Book Value High	-135.21	- -	-5.71	42.88	7.75	9.31	8.36	7.81	4.24	6.86	11.19	6.47	-5.92	-3.38	-2.72
Price/Book Value Low	-9.77	- -	-0.8	4.06	1.27	0.61	0.82	0.59	1.67	2.5	3.01	0.83	-1.21	-1.36	-0.15
Price/Tangible Book Value	-16.53	- -	-2.12	-2.41	-3.07	-6.94	3.43	1.21	38.07	10.91	12.75	2.01	-2.55	-1.08	-0.98
Price/Tangible Book Value Average	-54.22	- -	-1.36	-4.61	-6.56	-33.96	7.23	5.6	45.67	12.43	9.94	6.52	-1.74	-1.65	-0.46
Price/Tangible Book Value High	-135.21	- -	-3.01	-8.7	-12.91	-86.62	23.12	12.04	72.99	25.3	24.39	10.46	-4.14	-2.62	-2.56
Price/Tangible Book Value Low	-9.77	- -	-0.42	-0.82	-2.12	-5.68	2.28	0.9	28.7	9.21	6.56	1.35	-0.84	-1.05	-0.14
Price/Sales	0.5	12.66	624.69	93.89	45.34	16.65	56.1	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	1.65	12.61	402.39	179.6	96.95	81.45	118.18	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	4.12	18.09	887.05	338.93	190.81	207.74	377.69	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	0.3	5.79	124.94	32.06	31.33	13.62	37.21	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-0.43	-1.96	-8.04	-3.05	-2.2	-0.41	-0.7	-0.42	-1.4	-2.68	-5.6	-1.31	-2.46	-1.78	-8.83
Price/Cash Flow Average	-1.4	-1.96	-5.18	-5.84	-4.71	-2	-1.48	-1.93	-1.67	-3.05	-4.37	-4.25	-1.68	-2.71	-4.14
Price/Cash Flow High	-3.48	-2.81	-11.42	-11.03	-9.27	-5.09	-4.73	-4.15	-2.68	-6.22	-10.72	-6.82	-4	-4.31	-22.98
Price/Cash Flow Low	-0.25	-0.9	-1.61	-1.04	-1.52	-0.33	-0.47	-0.31	-1.05	-2.26	-2.88	-0.88	-0.81	-1.73	-1.26
Price/Free Cash Flow Average	-1.51	-1.98	-5.27	-10.15	-4.81	-2.05	-1.53	-1.95	-2.03	-3.2	-4.62	-4.56	-2.03	-4.65	-4.23
Price/Free Cash Flow High	-3.75	-2.84	-11.61	-19.16	-9.47	-5.23	-4.89	-4.18	-3.25	-6.51	-11.34	-7.32	-4.83	-7.42	-23.48
Price/Free Cash Flow Low	-0.27	-0.91	-1.63	-1.81	-1.55	-0.34	-0.48	-0.31	-1.28	-2.37	-3.05	-0.94	-0.98	-2.98	-1.29
EV/Sales Average	22.86	4.2	475.6	174.86	85.68	117.63	131.12	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	57.9	4.2	1,349.77	344.24	187.74	329.28	517.05	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	3.63	4.2	- -	18	14.34	3.95	10.72	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-16.93	-0.7	-3.14	-5.92	-4.11	-2.27	-1.51	-2.22	-2	-3.27	-6.33	-4.98	-4.67	-5.33	-13.02
EV/EBITDA High	-42.88	-0.7	-8.91	-11.65	-9.01	-6.36	-5.96	-5.69	-3.31	-6.49	-13.77	-7.42	-7.43	-6.79	-29.46
EV/EBITDA Low	-2.69	-0.7	0.16	-0.61	-0.69	-0.08	-0.12	0.31	-1.19	-2.47	-4.6	-1.78	-3.65	-4.44	-10.51
EV/EBIT Average	-16.22	-0.69	-3.11	-5.84	-3.98	-2.21	-1.46	-2.14	-1.86	-3.11	-6.02	-4.86	-4.56	-5.16	-12.38
EV/EBIT High	-41.08	-0.69	-8.83	-11.5	-8.72	-6.19	-5.74	-5.48	-3.07	-6.15	-13.09	-7.24	-7.26	-6.58	-28.01
EV/EBIT Low	-2.57	-0.69	0.16	-0.6	-0.67	-0.07	-0.12	0.3	-1.11	-2.34	-4.37	-1.73	-3.56	-4.3	-9.99
Last Price	1,540	1,225	3,500	1,435	557.2	61.6	14.14	2.89	3.25	2.98	5.48	1.24	3.24	1.85	6.28
High Price	12,600	1,750	4,970	5,180	2,345	768.6	95.2	28.7	6.23	6.92	10.48	6.46	5.26	4.48	16.34
Enterprise Value Average	199	3	39	72	41	31	15	23	36	67	143	180	187	219	387
Enterprise Value High	505	3	109	141	89	86	59	58	59	133	312	267	297	279	875
Enterprise Value Low	32	3	-2	7	7	1	1	-3	21	51	104	64	146	182	312

Shares Outstanding	- -	- -	- -	- -	- -	- -	1	2	10	19	27	36	36	36	36
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	8	16	24	34	36	59	36
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	7	16	24	34	36	36	36
Revenue per Share	3,058.95	96.76	5.6	15.28	12.29	3.7	0.25	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-4,130.18	-577.67	-848.79	-451.7	-256.06	-191.56	-21.88	-7.53	-2.65	-1.25	-0.94	-1.05	-1.11	-1.14	-0.82
Operating Income per Share	-4,311.23	-586.42	-856.61	-457.61	-264.6	-196.81	-22.7	-7.81	-2.85	-1.32	-0.99	-1.08	-1.13	-1.17	-0.86
Basic EPS, GAAP	-7,270.18	-161.76	-5,052.71	636.82	-279.27	-345.44	-28.14	-8.93	-2.91	-1.35	-0.96	-1.08	-1.91	-0.52	-4.8
Basic EPS from Cont Ops	-7,270.18	-620.81	-4,467.25	863.53	-13.35	-268.06	-28.14	-8.93	-2.91	-1.35	-0.96	-1.08	-1.91	-0.52	-4.8
Diluted EPS, GAAP	-7,270.18	-161.76	-5,052.71	405.3	-279.27	-345.44	-27.34	-8.9	-2.43	-1.35	-0.96	-1.08	-1.91	-0.32	-4.8
Diluted EPS from Cont Ops	-7,270.18	-620.81	-4,467.25	549.59	-13.35	-268.06	-27.34	-8.9	-2.43	-1.35	-0.96	-1.08	-1.91	-0.32	-4.8
Dividend per Share	- -	- -	- -	- -	- -	1.14	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3,615.79	-623.87	-435.22	-469.79	-253.06	-150.92	-20.15	-6.92	-2.33	-1.11	-0.98	-0.95	-1.31	-1.04	-0.71
Free Cash Flow per Basic Share	-3,874.74	-631.59	-442.28	-514.7	-258.49	-154.89	-20.27	-6.95	-2.36	-1.16	-1.03	-1.01	-1.54	-1.09	-0.73
Cash & Equivalents per Share	128.86	- -	780.6	231.31	222.96	48.49	7.56	3.54	0.61	0.52	0.38	0.41	0.37	0.26	0.24
Book Value per Share	-93.19	- -	-871.07	120.8	302.53	82.56	11.39	3.67	1.47	1.01	0.94	1	-0.89	-1.33	-6
Tangible Book Value per Share	-93.19	- -	-1,653.7	-595.41	-181.61	-8.87	4.12	2.38	0.09	0.27	0.43	0.62	-1.27	-1.71	-6.38

Armata Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)